Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis

Xiang,Wei; Jiang,Ting; Guo,Fengjing; Gong,Chen; Yang,Kaixiang; Wu,Yingxing; Huang,Xin; Cheng,Weiting; Xu,Kai

doi:10.3892/or.2014.3372

October 2014 Volume 32 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October 2014 Volume 32 Issue 4

Full Size Image

Article

Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis

Authors:
- Wei Xiang
- Ting Jiang
- Fengjing Guo
- Chen Gong
- Kaixiang Yang
- Yingxing Wu
- Xin Huang
- Weiting Cheng
- Kai Xu
View Affiliations / Copyright

Affiliations: Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Oncology, Wuhan Integrated Traditional Chinese Medicine and Western Medicine Hospital, Wuhan No. 1 Hospital, Wuhan, Hubei 430030, P.R. China
Pages: 1622-1630
|
Published online on: July 31, 2014

https://doi.org/10.3892/or.2014.3372
Expand metrics +

Abstract

Chondrosarcoma is a type of malignant bone tumor secreting cartilage-like matrix. In clinical treatment, there is no frequently used drug treatment option except for surgical resection. Hedgehog (HH) pathway is a classical signaling pathway that regulates normal cartilage cell development. In order to detect the role that HH pathway plays in chondrosarcoma, we used immunohistochemistry and found this tumor clearly expressed HH pathway-related proteins. Treatment with HH pathway inhibitor-4 (HPI-4) could significantly decrease human chondrosarcoma cell proliferation, invasion and migration ability. Furthermore, HPI-4 could distinctly disturb HH pathway-mediated ciliogenesis and suppress primary cilia-related protein intraflagellar transport protein IFT88 expression. HH downstream effect molecular GLI2 was restrained to block parathyroid hormone-related protein and affect MAPK/ERK-regulated matrix metalloproteinases (MMP2 and MMP9). These results indicated that activated HH pathway existed in chondrosarcoma and HPI-4 could be a new therapeutic option specific to chondrosarcoma expressing elevated levels of HH pathway.

View Figures

View References

1	Björnsson J, McLeod RA, Unni KK, et al: Primary chondrosarcoma of long bones and limb girdles. Cancer. 83:2105–2119. 1998.PubMed/NCBI
2	Tiet TD, Hopyan S, Nadesan P, et al: Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am J Pathol. 168:321–330. 2006. View Article : Google Scholar : PubMed/NCBI
3	Xu K, Guo F, Zhang S, et al: Blocking Ihh signaling pathway inhibits the proliferation and promotes the apoptosis of PSCs. J Huazhong Univ Sci Technolog Med Sci. 29:39–44. 2009. View Article : Google Scholar : PubMed/NCBI
4	Hassounah NB, Bunch TA and McDermott KM: Molecular pathways: the role of primary cilia in cancer progression and therapeutics with a focus on Hedgehog signaling. Clin Cancer Res. 18:2429–2435. 2012. View Article : Google Scholar : PubMed/NCBI
5	Johnson RW, Merkel AR, Danilin S, et al: 6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2. Anticancer Res. 31:2705–2712. 2011.PubMed/NCBI
6	Johnson RW, Nguyen MP, Padalecki SS, et al: TGF-β promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res. 71:822–831. 2011.
7	Oue T, Uehara S, Yamanaka H, et al: Hedgehog signal inhibitors suppress the invasion of human rhabdomyosarcoma cells. Pediatr Surg Int. 29:1153–1158. 2013. View Article : Google Scholar : PubMed/NCBI
8	Che J, Zhang FZ, Zhao CQ, et al: Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells. Oncol Lett. 5:1417–1421. 2013.PubMed/NCBI
9	Zhuang Z, Wang K, Cheng X, et al: LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway. PLoS One. 8:e674312013. View Article : Google Scholar : PubMed/NCBI
10	Basten SG, Willekers S, Vermaat JS, et al: Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue. Cilia. 2:22013. View Article : Google Scholar : PubMed/NCBI
11	Yan R, Peng X, Yuan X, et al: Suppression of growth and migration by blocking the Hedgehog signaling pathway in gastric cancer cells. Cell Oncol (Dordr). 36:421–435. 2013. View Article : Google Scholar : PubMed/NCBI
12	Ho L, Ali SA, Al-Jazrawe M, et al: Primary cilia attenuate hedgehog signalling in neoplastic chondrocytes. Oncogene. 32:5388–5396. 2013. View Article : Google Scholar : PubMed/NCBI
13	Lauth M, Bergström A, Shimokawa T, et al: Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA. 104:8455–8460. 2007. View Article : Google Scholar : PubMed/NCBI
14	Wu VM, Chen SC, Arkin MR, et al: Small molecule inhibitors of Smoothened ciliary localization and ciliogenesis. Proc Natl Acad Sci USA. 109:13644–13649. 2012. View Article : Google Scholar : PubMed/NCBI
15	Goto H, Inoko A and Inagaki M: Cell cycle progression by the repression of primary cilia formation in proliferating cells. Cell Mol Life Sci. 70:3893–3905. 2013. View Article : Google Scholar : PubMed/NCBI
16	Irigoín F and Badano JL: Keeping the balance between proliferation and differentiation: the primary cilium. Curr Genomics. 12:285–297. 2011.PubMed/NCBI
17	Proulx-Bonneau S and Annabi B: The primary cilium as a biomarker in the hypoxic adaptation of bone marrow-derived mesenchymal stromal cells: a role for the secreted frizzled-related proteins. Biomark Insights. 6:107–118. 2011.PubMed/NCBI
18	McGlashan SR, Haycraft CJ, Jensen CG, et al: Articular cartilage and growth plate defects are associated with chondrocyte cytoskeletal abnormalities in Tg737^orpk mice lacking the primary cilia protein polaris. Matrix Biol. 26:234–246. 2007. View Article : Google Scholar : PubMed/NCBI
19	Rich DR and Clark AL: Chondrocyte primary cilia shorten in response to osmotic challenge and are sites for endocytosis. Osteoarthritis Cartilage. 20:923–930. 2012. View Article : Google Scholar : PubMed/NCBI
20	Das S, Tucker JA, Khullar S, et al: Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases. PLoS One. 7:e343742012. View Article : Google Scholar : PubMed/NCBI
21	Mak IW, Turcotte RE and Ghert M: Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells. Bone. 55:198–207. 2013. View Article : Google Scholar : PubMed/NCBI
22	Bartsch JE, Staren ED and Appert HE: Matrix metalloproteinase expression in breast cancer. J Surg Res. 110:383–392. 2003. View Article : Google Scholar : PubMed/NCBI
23	Chung TW, Lee YC and Kim CH: Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J. 18:1123–1125. 2004.PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Related Articles